0001903671-22-000001.txt : 20220110 0001903671-22-000001.hdr.sgml : 20220110 20220110160934 ACCESSION NUMBER: 0001903671-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220110 DATE AS OF CHANGE: 20220110 EFFECTIVENESS DATE: 20220110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Glycologix, Inc. CENTRAL INDEX KEY: 0001903671 IRS NUMBER: 871992372 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-428651 FILM NUMBER: 22521359 BUSINESS ADDRESS: STREET 1: 100 CUMMINGS CENTER, SUITE 451C CITY: BEVERLY STATE: MA ZIP: 01915 BUSINESS PHONE: 6174802536 MAIL ADDRESS: STREET 1: 100 CUMMINGS CENTER, SUITE 451C CITY: BEVERLY STATE: MA ZIP: 01915 D 1 primary_doc.xml X0708 D LIVE 0001903671 Glycologix, Inc. 100 CUMMINGS CENTER, SUITE 451C BEVERLY MA MASSACHUSETTS 01915 6174802536 DELAWARE None None Corporation true 2021 Daniel Deardorf 100 Cummings Center, Suite 451C Beverly MA MASSACHUSETTS 01915 Executive Officer Director George Adaniya 100 Cummings Center, Suite 451C Beverly MA MASSACHUSETTS 01915 Director Michael Chester 100 Cummings Center, Suite 451C Beverly MA MASSACHUSETTS 01915 Director Other Technology No Revenues 06b false 2021-12-24 false true true false 0 3000000 1800000 1200000 false 28 0 0 225000 true Represents aggregate compensation to officers and directors for one year. false Glycologix, Inc. Daniel Deardorf Daniel Deardorf Chief Executive Officer 2022-01-10